| Gene symbol | FGF2 | Synonyms | BFGF, FGF-2, FGFB, HBGF-2 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q28.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | fibroblast growth factor 2 | ||||
| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC0054 |
| Trial ID | NCT00620217 |
| Therapeutic/Target gene | 52 |
| Therapy | other |
| Treatment | Coronary Artery Disease |
| Co-treatment | in vivo |
| Generation | Adult, Older_Adult |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Therapeutic Angiogenesis Using Human VEGF-A165/bFGF Plasmid Injected Percutaneously Into the Ischemic Myocardium of No-option" Coronary Artery Disease Patients; Double-blind Placebo Controlled Study DNA therapy Gene transfer ph-VEGF-A/FGF VEGFA|FGF2 Therapeutic gene plasmid intramyocardial injection "a total dose of 0.5 mg, 10 injections of 0.2 ml each |
| Year | 2008 |
| Country | Poland |
| https://pubmed.ncbi.nlm.nih.gov/21392615/ | |||||
|
|||||